Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Cognitive and Adaptive Effects of Early Growth Hormone Treatment in Prader-Willi Syndrome Patients: A Cohort Study
Aitana Ayet-Roger1,2, Lorena Joga-Elvira2,3, Assumpta Caixàs3,4,5
1Clinical and Health Psychology Department, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Insights
Early growth hormone (GH) treatment for Prader-Willi Syndrome (PWS) significantly improves cognitive and adaptive outcomes. Administering GH before age two yields greater benefits for children with PWS.
Area of Science:
- Neuroscience
- Genetics
- Pediatrics
Background:
- Prader-Willi Syndrome (PWS) is a genetic neurodevelopmental disorder.
- PWS is associated with intellectual disability, obesity, and hyperphagia.
- Growth hormone (GH) therapy may enhance cognitive function in PWS patients.
Purpose of the Study:
- To compare cognitive and adaptive performance in PWS patients based on the timing of GH treatment.
- To evaluate the impact of early-stage GH intervention (before age 2) versus later treatment.
Main Methods:
- Cognitive performance assessed using Weschler scales.
- Adaptive behavior evaluated with the DABS scale.
- Non-parametric statistical tests used for score analysis.
Main Results:
- Patients treated with GH before age 2 (Group 1) showed significantly higher scores in Total Intelligence Quotient (TIQ), General Ability Index (GAI), and General Adaptive Behavior (GAB).
- Group 1 demonstrated superior cognitive and adaptive performance compared to Group 2 (later treatment).
Conclusions:
- Early GH administration (before age 2) is recommended for PWS patients.
- Early intervention maximizes cognitive and adaptive benefits in Prader-Willi Syndrome.
Background:
Prader-Willi Syndrome (PWS) is a genetically based neurodevelopmental disease characterized by obesity, hyperphagia, and mild to moderate intellectual disability. Treatment with growth hormone (GH) could provide cognitive benefits. The objective of the present study was to compare the cognitive and adaptive performance of 31 patients with genetically confirmed PWS grouped in two cohorts, one treated with GH before 2 years old (Group 1) and the other receiving the treatment later (Group 2).
Method:
We compared two variables necessary to diagnose intellectual disability: intellectual performance, using the Weschler scales, and adaptive behavior, using the DABS scale. The scores were analyzed by means of non-parametric statistical tests.
Results:
Group 1 (n = 10) obtained higher and statistically significant scores in Total Intelligence Quotient (TIQ), General Ability Index (GAI), and General Adaptive Behavior (GAB), implying better cognitive and adaptive performance compared to Group 2.
Conclusions:
Treatment with GH should be administered in the early stage of development (before 2 years old) to obtain greater benefits at the cognitive and adaptive levels.
More Related Videos
05:04Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Nature and Nurture
Biological Influences on Intelligence
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Signs of Puberty